BIOCAUSE HEILEN PHARMA: Ibuprofen suspension has obtained the drug registration certificate
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, BIOCAUSE HEILEN PHARMA announced that the company recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration ("NMPA"), involving the product: "Ibuprofen Suspension". The announcement stated that the registration classification of the ibuprofen suspension is Category 4 chemical drugs, which were reviewed and approved according to the technical requirements consistent with the quality and efficacy of the reference preparation, and after approval, it is deemed to have passed the consistency evaluation of the quality and efficacy of generic drugs
According to the Zhitong Finance APP, BIOCAUSE HEILEN PHARMA (301211.SZ) announced that it recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration ("NMPA"), involving the product: "Ibuprofen Suspension".
The announcement stated that the registration classification of the Ibuprofen Suspension is a Class 4 chemical drug, which was reviewed and approved according to the technical requirements consistent with the quality and efficacy of the reference preparation, and is deemed to have passed the consistency evaluation of the quality and efficacy of generic drugs after approval